Description of Business and Basis of Presentation (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended	9 Months Ended
	Jun. 30, 2015	Jul. 31, 2014	Sep. 30, 2015	Sep. 30, 2015	Sep. 30, 2014
Date of incorporation				Dec. 05, 1986
State of incorporation				Nevada
Shares issued	286,500			272,000
Payment for business combination				$ 50,000
Note Financing [Member]
Principal amount, note offering		$ 500,000		$ 121,500
Shares issued		200,000		243,000
Shares issued, value		$ 200,000
Note interest rate		10.00%
Maturity date		Dec. 31, 2015		Dec. 31, 2015
Note Financing [Member] | Commitments to Extend Credit [Member]
Shares issued			286,500
Global Cancer [Member]
Share value				$ .01
Business combination agreement date				Sep. 03, 2015
Ownership percent			100.00%	100.00%
Payment for business combination				$ 50,000
Business combination contingent payment terms				In the event the Company and Global execute definitive merger documents contemplated by the Global LOI on or before the Termination Date, Global will issue to the Company that number of shares of Global’s common stock equal to 10% of the then outstanding shares of Global’s common stock, on a fully-diluted basis as payment of the Global Advance.